Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: A case-control study

22Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The incidence and disease severity of Clostridium difficile infection are rising. There is increasing evidence of a potential association between proton-pump inhibitors (PPI) and C.difficile infection. We performed a case-control study to examine the relationship between PPI and polymerase chain reaction (PCR)-proven C.difficile infection in 137 hospitalised patients in a tertiary hospital in Western Australia. Only antibiotic exposure within 3months prior to onset of diarrhoea was associated with PCR-proven C.difficile infection (odds ratio 5.97, 95% confidence interval 2.40-14.8, P= 0.001). A restricted analysis on those who had exposure to antibiotics within 3months before the onset of diarrhoea did not change the negative association between PPI exposure and PCR-proven C.difficile infection. Long-term PPI usage and intensity of PPI exposure prior to onset of diarrhoea were not significantly associated with C.difficile infection. © 2012 The Authors. Internal Medicine Journal © 2012 Royal Australasian College of Physicians.

Cite

CITATION STYLE

APA

Leonard, A. D., Ho, K. M., & Flexman, J. (2012). Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: A case-control study. Internal Medicine Journal, 42(5), 591–594. https://doi.org/10.1111/j.1445-5994.2012.02770.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free